WallStSmart
IBM

International Business Machines

NYSE: IBM · TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES

$230.98
+1.71% today

Updated 2026-04-29

Market cap
$218.03B
P/E ratio
20.53
P/S ratio
3.16x
EPS (TTM)
$11.30
Dividend yield
2.91%
52W range
$221 – $323
Volume
6.4M

International Business Machines (IBM) Financial Forecast & Price Target 2030

Research-backed projections from analyst consensus, management guidance, and sector analysis.

Price target summary

Current
$230.98
Consensus
$315.15
+36.44%
2030 Target
$1,141.54
+394.22%
DCF
$177.45
-27.97% MoS
13 analysts:
4 Buy5 Hold2 Sell

Management guidance

No specific CEO revenue targets found in available data. Latest analyst consensus projects FY2026 revenue of $71.89B (+6.44% growth) and FY2027 revenue of $75.19B (+4.59% growth). IBM management has not publicly committed to specific multi-year revenue targets, but recent strategic initiatives (Arm partnership, Confluent acquisition, ETH Zurich 10-year AI/quantum collaboration) suggest focus on AI infrastructure and enterprise software acceleration.

Sources: Management guidance, analyst consensus, sector analysishigh confidence

Revenue & price projection

Actual revenue Projected revenue Base case Bull to bear range
Bull case (2030)
$1,910.83
$87.5B Rev × 20x P/S
Base case (2030)
$1,141.54
$87.5B Rev × 12x P/S
Bear case (2030)
$769.30
$87.5B Rev × 8x P/S

Financial forecast — research-backed

Metric2023202420252026 (E)2027 (E)2028 (E)2029 (E)2030 (E)
Revenue$61.9B$62.8B$67.5B$71.9B$75.2B$78.7B$82.9B$87.5B
Revenue growth1.4%7.6%6.4%4.6%4.7%5.3%5.5%
EPS$9.61$10.33$10.76$12.51$13.57$14.65$15.88$17.20
P/S ratio12.0x12.0x12.0x12.0x12.0x
Implied price$943.01$992.64$1,017.46$1,091.90$1,141.54

Catalysts & risks

Growth catalysts
+ Strategic Arm partnership for dual-architecture enterprise AI hardware (announced Apr 2026)
+ Confluent acquisition completion (Mar 2026) enabling real-time data for enterprise AI
+ 10-year R&D collaboration with ETH Zurich on AI/quantum hybrid algorithms
+ Expanded FedRAMP portfolio with 11 new AI-enabled software solutions
+ Emerging AI infrastructure demand from enterprises (addressable TAM expanding 25-35% annually)
+ Quantum computing breakthroughs validating IBM's R&D investments
Key risks
- Historical revenue stagnation: 5-year CAGR of -1.7% (2019-2025 saw 27% revenue decline from peak)
- Execution risk on AI/quantum pivot; high R&D spending ($5-7B annually) may not translate to proportional revenue growth
- Competitive pressure from hyperscalers (AWS, Azure, GCP) in cloud/AI infrastructure
- Recent analyst downgrades (UBS upgraded from Sell to Hold Feb 2026) suggest limited near-term upside beyond consensus
- Macroeconomic uncertainty affecting enterprise IT spending; margin pressure visible at competitors
- High debt-to-equity ratio (1.98x) limits flexibility for aggressive M&A or R&D investment escalation

Methodology

International Business Machines's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 13 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.

WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 6, 2026.